コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tomography, magnetic resonance imaging, and endoscopic ultrasonography.
2 ncer staging," "endoscopic ultrasound," and "endoscopic ultrasonography."
3 80 patients with cancer, the sensitivity of endoscopic ultrasonography (98% [95% CI, 91% to 100%]) f
5 tumors in patients recommended for surgery, endoscopic ultrasonography and CT correctly identified 6
6 tumors in patients recommended for surgery, endoscopic ultrasonography and CT correctly identified 8
10 sis of clinical history and abnormalities on endoscopic ultrasonography and ERCP and were referred fo
11 Clinical data combined with imaging studies (endoscopic ultrasonography and ERCP) can be used to iden
13 omography-pancreas angiography, laparoscopy, endoscopic ultrasonography, and fine-needle aspiration c
14 esophagus was assessed by endoscopy, biopsy, endoscopic ultrasonography, and high-resolution impedanc
15 es of endoscopic retrograde pancreatography, endoscopic ultrasonography, and magnetic resonance imagi
17 etic resonance cholangiopancreatography, and endoscopic ultrasonography-are enabling more accurate di
18 to the initial staging of esophageal cancer, endoscopic ultrasonography-based measurement of reductio
21 The new Rosemont consensus classification of endoscopic ultrasonography criteria for chronic pancreat
22 tion endoscopy with random gastric biopsies, endoscopic ultrasonography, CT, and PET scans to evaluat
23 fficult, although newer techniques utilizing endoscopic ultrasonography-elastography and MRI hold pro
26 ical staging with the use of laparoscopy and endoscopic ultrasonography (EUS) and to improve R0 resec
28 tection of malignancy in patients undergoing endoscopic ultrasonography (EUS) fine-needle aspiration
34 ICE ADVICE 7: Magnetic resonance imaging and endoscopic ultrasonography (EUS) should be used in combi
35 r study is needed to improve the accuracy of endoscopic ultrasonography (EUS) to diagnose chronic pan
36 subset of patients were selected to undergo endoscopic ultrasonography (EUS) to estimate EI post abl
37 trograde cholangiopancreatography (ERCP) and endoscopic ultrasonography (EUS) under procedural sedati
43 , published since April 2002, on the role of endoscopic ultrasonography for staging of esophageal can
45 e assisted to a change of paradigm involving Endoscopic Ultrasonography, from a pure diagnostic techn
47 ancreatitis is, indeed, chronic, the role of endoscopic ultrasonography-guided celiac plexus block sh
48 tibiotic prophylaxis for patients undergoing endoscopic ultrasonography-guided fine needle aspiration
55 s to summarize indications and techniques of endoscopic ultrasonography-guided visceral anastomoses.
59 cause long-term follow-up data on the use of endoscopic ultrasonography in this respect are not avail
63 al staging accuracy for esophageal cancer by endoscopic ultrasonography is superior to other currentl
67 nt; and the use of specialist consultations, endoscopic ultrasonography, positron emission tomography
68 oma cannot be identified by SRS or STIR-MRI, endoscopic ultrasonography should be undertaken because
69 ecently published studies on the outcomes of endoscopic ultrasonography support its utility in the st
70 re on the diagnostic and therapeutic role of endoscopic ultrasonography to handle pancreatic fluid co
71 confirmed at surgical resection (n = 12) or endoscopic ultrasonography (US) with cystic fluid analys
72 langiopancreatography (MRCP), four patients; endoscopic ultrasonography (US), 21 patients; endoscopic
73 ysts that were 3 cm or smaller at surgery or endoscopic ultrasonography (US)-guided cyst fluid aspira
76 asing facility volume and ability to perform endoscopic ultrasonography were associated inversely wit
78 f PDAC requires invasive procedures, such as endoscopic ultrasonography, which has inherent risks and
79 ts with cCR based on endoscopic biopsies and endoscopic ultrasonography with fine-needle aspiration i